Highlights ERS 2025

Author : Sanofi

Editorial team

Sep. 27^th to Oct. 1^st 2025 | Amsterdam, Netherlands

The European Respiratory Society annual congress took place in Amsterdam this year. Whether or not you were able to attend the congress, here is an overview of the highlights of this major European event bringing together the scientific community in respiratory care.

Distinguished international experts delivered outstanding lectures on Asthma and COPD.

Highlights captured by the Swedish Immunology Team at ERS

Nikolaos Lazarini, Karolinska University hospital, Dear colleagues! In this 5 minute video, I’ll share my reflection from ERS 2025. Several clinically relevant findings, especially around biomarkers and personalized treatment approaches that could benefit Swedish patients. Some results may be implemented short-term, such as adjusting diagnostic strategies or treatment pathways. There was clear momentum around biomarker-driven care, with new trends pointing toward more precise phenotyping and prediction of treatment response.

Tarek Bass, Medical Advisor at Sanofi, presents the ProVENT study—showing Dupilumab’s sustained effectiveness over two years in severe asthma, with improved control, lung function, and remission.

Alma Hrnjadovic, Medical Advisor at Sanofi, presents results from Post hoc analysis of pooled BOREAS and NOTUS data - showing how Dupilumab vs placebo significantly reduced the time-to-first severe exacerbation event.

Videos

Highlights ERS 2025, reflection, Dr Nikolaos Lazarini, Karolinska University hospital

The ProVent study – a short summary under 2 minutes

Learn more about the poster here

Results from Post hoc analysis of pooled BOREAS and NOTUS data - a short summary under 2 minutes

Learn more about the poster here

Interview with:

Prof. Dr. Guy Brusselle

Dive into the future of respiratory medicine in this interview with the distinguished Prof. Guy Brusselle, sharing groundbreaking insights from the European Respiratory Society Congress.

Prof. Dr. Guy Brusselle

Professor of Respiratory Medicine at the University Hospital of Ghent, Belgium Chair of Board, Global Initiative for Asthma (GINA)

Interview with:

Prof. Dr. Wim Janssens

Prof. Wim Janssens reveals developments in COPD management straight from the European Respiratory Society Congress. Dive into his expert insights as he unpacks exciting developments that could improve how we approach COPD care.

Prof. Dr. Wim Janssens

Professor of Respiratory Medicine at the University Hospital of Leuven, Belgium Head of the Department of Chronic Diseases and Metabolism at KU Leuven, Belgium